Martina Ferraresi

Martina Ferraresi

Auto-generated profile, based on publicly available information

Martina Ferraresi

SS Nephrology, ASOU San Luigi, Department of Clinical and Biological Sciences, University of Torino, Torino, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2012 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli
LBLaura Davico Bonino
Laura Davico Bonino
PCPaola Campisi
Paola Campisi
FVFederica Neve Vigotti
Federica Neve Vigotti
MFMartina Ferraresi
Martina Ferraresi
GRGabriella Restagno
Gabriella Restagno
MELAS syndrome (MIM ID#540000), an acronym for Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like episodes, is a genetically heterogeneous mitochondrial disorder with protean manifestations and occasional kidney involvement. Interest in the latter is rising due to the identification of cases with predominant kidney involvement and to the hypothesis of a link between mitochondrial DNA and kidney neoplasia. We report the case of a 41-year-old male with full blown MELAS syndrome, with lactic acidosis and neurological impairment, affected by the "classic" 3243A > G mutation of mitochondrial DNA, with kidney cancer. After unilateral nephrectomy, he rapidly developed severe kidney functional impairment, with nephrotic proteinuria. Analysis of the kidney tissue at a distance from the two tumor lesions, sampled at the time of nephrectomy was performed in the context of normal blood pressure, recent onset of diabetes and before the appearance of proteinuria. The morphological examination revealed a widespread interstitial fibrosis with dense inflammatory infiltrate and tubular atrophy, mostly with thyroidization pattern. Vascular lesions were prominent: large vessels displayed marked intimal fibrosis and arterioles had hyaline deposits typical of hyaline arteriolosclerosis. These severe vascular lesions explained the different glomerular alterations including ischemic and obsolescent glomeruli, as is commonly observed in the so-called "benign" arteriolonephrosclerosis. Some rare glomeruli showed focal segmental glomerulosclerosis; as the patient subsequently developed nephrotic syndrome, these lesions suggest that silent ischemic changes may result in the development of focal segmental glomerulosclerosis secondary to nephron loss. Nephron loss may trigger glomerular sclerosis, at least in some cases of MELAS-related nephropathy. Thus the incidence of kidney disease in the "survivors" of MELAS syndrome may increase as the support therapy of these patients improves.

21 June 2013 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
MFMartina Ferraresi
Martina Ferraresi
RCRoberta Clari
Roberta Clari
IMIrene Moro
Irene Moro
EBElena Banino
Elena Banino
EBEnrico Boero
Enrico Boero
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli
Complementary and Alternative Medicines (CAMs) are increasingly practiced in the general population; it is estimated that over 30% of patients with chronic diseases use CAMs on a regular basis. CAMs are also used in hospital settings, suggesting a growing interest in individualized therapies. One potential field of interest is pain, frequently reported by dialysis patients, and seldom sufficiently relieved by mainstream therapies. Gentle-touch therapies and Reiki (an energy based touch therapy) are widely used in the western population as pain relievers. By integrating evidence based approaches and providing ethical discussion, this debate discusses the pros and cons of CAMs in the dialysis ward, and whether such approaches should be welcomed or banned. In spite of the wide use of CAMs in the general population, few studies deal with the pros and cons of an integration of mainstream medicine and CAMs in dialysis patients; one paper only regarded the use of Reiki and related practices. Widening the search to chronic pain, Reiki and related practices, 419 articles were found on Medline and 6 were selected (1 Cochrane review and 5 RCTs updating the Cochrane review). According to the EBM approach, Reiki allows a statistically significant but very low-grade pain reduction without specific side effects. Gentle-touch therapy and Reiki are thus good examples of approaches in which controversial efficacy has to be balanced against no known side effect, frequent free availability (volunteer non-profit associations) and easy integration with any other pharmacological or non pharmacological therapy. While a classical evidence-based approach, showing low-grade efficacy, is likely to lead to a negative attitude towards the use of Reiki in the dialysis ward, the ethical discussion, analyzing beneficium (efficacy) together with non maleficium (side effects), justice (cost, availability and integration with mainstream therapies) and autonomy (patients’ choice) is likely to lead to a permissive-positive attitude. This paper debates the current evidence on Reiki and related techniques as pain-relievers in an ethical framework, and suggests that physicians may wish to consider efficacy but also side effects, contextualization (availability and costs) and patient’s requests, according also to the suggestions of the Society for Integrative Oncology (tolerate, control efficacy and side effects).

27 February 2013 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli
Rossella AttiniRossella Attini
Rossella Attini
SPSilvia Parisi
Silvia Parisi
FVFederica N Vigotti
Federica N Vigotti
GDGermana Daidola
Germana Daidola
TTTullia Todros
Tullia Todros
Proteinuria and dilatation of the urinary tract are both relatively common in pregnancy, the latter with a spectrum of symptoms, from none to severe pain and infection. Proteinuria is a rare occurrence in acute obstructive nephropathy; it has been reported in pregnancy, where it may pose a challenging differential diagnosis with pre-eclampsia. The aim of the present study is to report on the incidence of proteinuria (≥0.3; ≥0.5 g/day) in association with symptomatic-severe urinary tract dilatation in pregnancy. Case series. Setting: Nephrological-Obstetric Unit dedicated to pregnancy and kidney diseases (January 2000-April 2011). Source: database prospectively updated since the start of the Unit. Retrospective review of clinical charts identified as relevant on the database, by a nephrologist and an obstetrician. From January 2000 to April 2011, 262 pregnancies were referred. Urinary tract dilatation with or without infection was the main cause of referral in 26 cases (predominantly monolateral in 19 cases): 23 singletons, 1 lost to follow-up, 1 twin and 1 triplet. Patients were referred for urinary tract infection (15 cases) and/or renal pain (10 cases); 6 patients were treated by urologic interventions (“JJ” stenting). Among them, 11 singletons and 1 triple pregnancy developed proteinuria ≥0.3 g/day (46.1%). Proteinuria was ≥0.5 g/day in 6 singletons (23.1%). Proteinuria resolved after delivery in all cases. No patient developed hypertension; in none was an alternative cause of proteinuria evident. No significant demographic difference was observed in patients with renal dilatation who developed proteinuria versus those who did not. An association with the presence of “JJ” stenting was present (5/6 cases with proteinuria ≥0.5 g/day), which may reflect both severer obstruction and a role for vescico-ureteral reflux, induced by the stent. Symptomatic urinary tract dilatation may be associated with proteinuria in pregnancy. This association should be kept in mind in the differential diagnosis with other causes of proteinuria in pregnancy, including pre-eclampsia.

8 June 2015 in Nephrology
Verified
Journal Article
Closed access
PDF file
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli
APAgostino De Pascale
Agostino De Pascale
OROlga Randone
Olga Randone
FVFederica Neve Vigotti
Federica Neve Vigotti
APAdriano Massimiliano Priola
Adriano Massimiliano Priola
AVAndrea Veltri
Andrea Veltri

16 October 2014
Verified
Journal Article
Closed access
MFMartina Ferraresi
Martina Ferraresi
MNMarta Nazha
Marta Nazha
FVFederica Neve Vigotti
Federica Neve Vigotti
APAmina Pereno
Amina Pereno
GGGerardo Di Giorgio
Gerardo Di Giorgio
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli

1 April 2014 in Giornale di Tecniche Nefrologiche e Dialitiche
Verified
Journal Article
Closed access
Giorgina PiccoliGiorgina Piccoli
Giorgina Piccoli
MFMartina Ferraresi
Martina Ferraresi
FVFederica Neve Vigotti
Federica Neve Vigotti
GGGerardo Di Giorgio
Gerardo Di Giorgio